300972 Stock Overview
Fujian Wanchen Biotechnology Co., Ltd engages in the research and development, cultivation, production, and sale of edible fungi in China. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 6/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
Fujian Wanchen Biotechnology Group Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥63.89 |
| 52 Week High | CN¥80.00 |
| 52 Week Low | CN¥17.69 |
| Beta | -0.037 |
| 11 Month Change | 6.45% |
| 3 Month Change | 130.32% |
| 1 Year Change | n/a |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 77.62% |
Recent News & Updates
Recent updates
Shareholder Returns
| 300972 | CN Food | CN Market | |
|---|---|---|---|
| 7D | -1.4% | -3.5% | -2.1% |
| 1Y | n/a | -6.7% | 2.8% |
Return vs Industry: Insufficient data to determine how 300972 performed against the CN Food industry.
Return vs Market: Insufficient data to determine how 300972 performed against the CN Market.
Price Volatility
| 300972 volatility | |
|---|---|
| 300972 Average Weekly Movement | 13.3% |
| Food Industry Average Movement | 6.9% |
| Market Average Movement | 8.4% |
| 10% most volatile stocks in CN Market | 12.7% |
| 10% least volatile stocks in CN Market | 5.7% |
Stable Share Price: 300972's share price has been volatile over the past 3 months compared to the CN market.
Volatility Over Time: 300972's weekly volatility (13%) has been stable over the past year, but is still higher than 75% of CN stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2011 | 4,972 | Li Qing Wang | www.vanchen.com |
Fujian Wanchen Biotechnology Co., Ltd engages in the research and development, cultivation, production, and sale of edible fungi in China. It offers flammulina velutipes; and crab-flavored, white jade, seafood mushrooms, etc. The company was founded in 2011 and is based in Zhangpu, China.
Fujian Wanchen Biotechnology Group Co., Ltd. Fundamentals Summary
| 300972 fundamental statistics | |
|---|---|
| Market cap | CN¥11.50b |
| Earnings (TTM) | CN¥57.69m |
| Revenue (TTM) | CN¥25.01b |
199.3x
P/E Ratio0.5x
P/S RatioIs 300972 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 300972 income statement (TTM) | |
|---|---|
| Revenue | CN¥25.01b |
| Cost of Revenue | CN¥22.41b |
| Gross Profit | CN¥2.60b |
| Other Expenses | CN¥2.54b |
| Earnings | CN¥57.69m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.32 |
| Gross Margin | 10.38% |
| Net Profit Margin | 0.23% |
| Debt/Equity Ratio | 105.2% |
How did 300972 perform over the long term?
See historical performance and comparison